Immunogenicity of recombinant classic swine fever virus CD8 + T lymphocyte epitope and porcine parvovirus VP2 antigen coexpressed by lactobacillus casei in swine via oral vaccination

Clinical and Vaccine Immunology

Volumn 18, Issue 11, 2011, Pages 1979-1986

  Xu, Yigang ^a,b   Cui, Lichun ^c   Tian, Changyong ^d   Zhang, Guocai ^c   Huo, Guicheng ^a   Tang, Lijie ^a   Li, Yijing ^a  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^b Heilongjiang Entry Exit Inspection and Quarantine Bureau   (China)

^c NORTHEAST FORESTRY UNIVERSITY   (China)

^d Liaoning Agricultural Technological College   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LACTOBACILLUS VACCINE; PROTEIN VP2;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPOTENTIATION; LACTOBACILLUS CASEI; MUCOSAL IMMUNITY; NONHUMAN; PESTIVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BLOOD; CAPSID PROTEINS; CD8-POSITIVE T-LYMPHOCYTES; CLASSICAL SWINE FEVER; CLASSICAL SWINE FEVER VIRUS; DRUG CARRIERS; EPITOPES, T-LYMPHOCYTE; GENETIC VECTORS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTESTINAL MUCOSA; LACTOBACILLUS CASEI; SURVIVAL ANALYSIS; SWINE; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 80455128598     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05204-11     Document Type: Article

References (52)

1. Alander, M., et al. 1999. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl. Environ. Microbiol. 65:351-354. (Pubitemid 29029667)
2. Altmeyer, R., et al. 1995. Attenuated Mengo virus: a new vector for live recombinant vaccines. J. Virol. 69:3193-3196.
3. Armengol, E., et al. 2002. Identification of T-cell epitopes in the structural and non-structural proteins of classical swine fever virus. J. Gen. Virol. 83:551-560. (Pubitemid 34183000)
4. Belyakov, I. M., et al. 2001. Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat. Med. 7:1320-1326. (Pubitemid 34007936)
5. Bergeron, J., J. Menezes, and P. Tijssen. 1993. Genome organization and mapping of transcription and translation products of the NADL-2 strain of porcine parvovirus. Virology 197:86-98.
6. Bican, J., M. Svoboda, and J. Drabek. 2002. Porcine parvovirus infection in boars in the Czech Republic. Acta Vet. Brno 71:45-49. (Pubitemid 36302540)
7. Brandtzaeg, P. 1994. Distribution and characteristics of mucosal immunoglobulin producing cells, p. 251-279. In W. Strober, J. Mestecky, M. E. Lamm, J. Bienenstock, and P. L. Ogra (ed.), Handbook of mucosal immunology. Academic Press, San Diego, CA.
8. Ceppi, M., et al. 2005. Identification of classical swine fever virus protein E2 as a target for cytotoxic T cells by using mRNA-transfected antigen-presenting cells. J. Gen. Virol. 86:2525-2534. (Pubitemid 41167601)
9. Chen, H. 2000. Recent advances in mucosal vaccine development. J. Control. Release 67:117-128. (Pubitemid 30303828)
10. Edwards, S., et al. 2000. Classical swine fever: the global situation. Vet. Microbiol. 73:103-119. (Pubitemid 30227286)
11. Elson, C. O., W. Ealding, and J. Lefkowiz. 1984. A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretion. J. Immunol. Methods 67:101-108. (Pubitemid 14156720)
12. + T cells in vivo: a study with the nucleoprotein of the lymphocytic choriomeningitis virus. Int. Immunol. 7:797-805.
13. Harding, C. V., and J. D. Pfeife. 1994. Antigen expressed by Salmonella typhimurium is processed for class I major histocompatibility complex presentation by macrophages but not infected epithelial cells. Immunology 83:670-674. (Pubitemid 24374104)
14. Ho, P. S., J. Kwang, and Y. K. Lee. 2005. Intragastric administration of Lactobacillus casei expressing transmissible gastroenteritis coronavirus spike glycoprotein induced specific antibody production. Vaccine 23:1335-1342. (Pubitemid 40127325)
15. Irvine, K. R., B. J. McCabe, S. A. Rosenberg, and N. P. Restifo. 1995. Synthetic oligonucleotide expressed by a recombinant vaccinia virus elicits therapeutic cytolytic T lymphocytes. J. Immunol. 154:4651-4657.
16. Ke, Y., Y. Li, and J. A. Kapp. 1995. Ovalbumin injected with complete Freund's adjuvant stimulates cytolytic responses. Eur. J. Immunol. 25:549-553.
17. Kilian, M., and M. W. Russel. 1994. Functions of mucosal immunoglobulins, p. 127-143. In W. Strober, J. Mestecky, M. E. Lamm, J. Bienenstock, and P. L. Ogra (ed.), Handbook of mucosal immunology. Academic Press, San Diego, CA.
18. Kimman, T. G., A. T. J. Bianchi, G. Wensvoort, T. G. M. de Bruin, and C. Meliefste. 1993. Cellular immune response to hog cholera virus (HCV): T cells of immune pigs proliferate in vitro upon stimulation with live HCV, but the E1 envelope glycoprotein is not a major T-cell antigen. J. Virol. 67:2922-2927. (Pubitemid 23118895)
19. Knoetig, S. M., A. Summerfield, M. Spagnuolo-Weaver, and K. C. McCullough. 1999. Immuno-pathogenesis of classical swine fever: role of monocytic cells. Immunol. 97:359-366. (Pubitemid 29274172)
20. Kovacsovics-Bankowski, M., K. Clark, B. Benacerraf, and K. L. Rock. 1993. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. U. S. A. 90:4942-4946. (Pubitemid 23182951)
21. London, S. D. 1994. Cytotoxic lymphocytes in mucosal effector sites, p. 325-336. In W. Strober, J. Mestecky, M. E. Lamm, J. Bienenstock, and P. L. Ogra (ed.), Handbook of mucosal immunology. Academic Press, San Diego, CA.
22. McGhee, J. R., et al. 1992. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10:75-88.
23. Medina, E., and C. A. Guzman. 2001. Use of live bacterial vaccine vectors for antigen delivery: potential and limitation. Vaccine 19:1573-1580. (Pubitemid 32175714)
24. Mengeling, W. L., K. M. Lager, and A. C. Vorwald. 2000. The effect of porcine parvovirus and porcine reproductive and respiratory syndrome virus on porcine reproductive performance. Anim. Reprod. Sci. 60-61:199-210. (Pubitemid 30397793)
25. Mittelholzer, C., C. Moser, J. D. Tratschin, and M. A. Hofmann. 2000. Analysis of classical swine fever virus replication kinetics allows differentiation of highly virulent from avirulent strains. Vet. Microbiol. 74:293-308. (Pubitemid 30265534)
26. Moennig, V. 2000. Introduction to classical swine fever: virus, disease and control policy. Vet. Microbiol. 73:93-102. (Pubitemid 30227285)
27. Molitor, T. W., H. S. Joo, and M. S. Collett. 1983. Porcine parvovirus: virus purification and structural and antigenic properties of virion polypeptides. J. Virol. 45:842-854. (Pubitemid 13225449)
28. Molitor, T. W., H. S. Joo, and M. S. Collett. 1984. Porcine parvovirus DNA: characterization of genomic and replicative form DNA of two virus isolates. Virology 137:241-254. (Pubitemid 14000570)
29. Moormann, R. J. M., et al. 1990. Molecular cloning and nucleotide sequence of hog cholera virus strain Brescia and mapping of the genomic region encoding envelope protein El. Virology 177:184-198. (Pubitemid 20218263)
30. Ogawa, T., Y. Asai, K. Yasuda, and H. Sakamoto. 2005. Oral immunoadjuvant activity of a new symbiotic Lactobacillus casei subsp casei in conjunction with dextran in BALB/c mice. Nutr. Res. 25:295-304. (Pubitemid 40354287)
31. Oliveira, M. L. S., et al. 2003. Expression of Streptococcus pneumoniae antigens, PsaA and PspA by Lactobacillus casei. FEMS Microbiol. Lett. 227:25-31.
32. Pauly, T., et al. 1995. Classical swine fever virus-specific cytotoxic T lymphocytes and identification of a T cell epitope. J. Gen. Virol. 76:3039-3049. (Pubitemid 26003113)
33. Perdigon, G., R. Fuller, and R. Raya. 2001. Lactic acid bacteria and their effect on the immune system. Curr. Issues Intest. Microbiol. 2:27-42. (Pubitemid 32401085)
34. Raha, A. R., N. R. Varma, and K. Yusoff. 2005. Cell surface display system for Lactococcus lactis: a novel development for oral vaccine. Appl. Microbiol. Biotechnol. 68:75-81. (Pubitemid 41202117)
35. Rau, H., H. Revets, C. Balmelli, K. C. McCullough, and A. Summerfield. 2006. Immunological properties of recombinant classical swine fever virus NS3 protein in vitro and in vivo. Vet. Res. 37:155-168. (Pubitemid 43067021)
36. Reveneau, N., M. C. Geoffroy, C. Locht, P. Chagnaud, and A. Mercenier. 2002. Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations. Vaccine 20:1769-1777. (Pubitemid 34242832)
37. Robinson, K., L. M. Chamberlain, K. M. Schofield, J. M. Wells, and R. W. F. Le Page. 1997. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat. Biotechnol. 15:653-657. (Pubitemid 27291166)
38. Rümenapf, T., R. Stark, G. Meyers, and H. J. Thiel. 1991. Structural proteins of hog cholera virus expressed by vaccinia virus: further characterization and induction of protective immunity. J. Virol. 65:589-597.
39. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
40. Scheppler, L., et al. 2002. Recombinant Lactobacillus johnsonii as a mucosal vaccine delivery vehicle. Vaccine 20:2913-2920. (Pubitemid 34785961)
41. Sedlik, C., et al. 1999. Intranasal delivery of recombinant parvovirus-like particles elicits cytotoxic T-cell and neutralizing antibody responses. J. Virol. 73:2739-2744. (Pubitemid 29135659)
42. + extrathymic T lymphocytes. Cell. Immunol. 168:291-296.
43. + cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nat. 344:873-875.
44. Tarradas, J., et al. 2010. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs. Vet. Microbiol. 142:51-58.
45. Terpstra, C., and G. Wensvoort. 1988. The protective value of vaccineinduced neutralising antibody titres in swine fever. Vet. Microbiol. 16:123-128.
46. Underdown, B. J., and J. Mestecky. 1994. Mucosal immunoglobulin, p. 79-98. In W. Strober, J. Mestecky, M. E. Lamm, J. Bienenstock, and P. L. Ogra (ed.), Handbook of mucosal immunology. Academic Press, San Diego, CA.
47. van Gennip, H. G. P., A. Bouma, P. A. van Rijn, M. N. Widjojoatmodjo, and R. J. M. Moormann. 2002. Experimental non-transmissible marker vaccines for classical swine fever (CSF) by transcomplementation of Erns or E2 of CSFV. Vaccine 20:1544-1556. (Pubitemid 34169794)
48. van Zijl, M., et al. 1991. Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera. J. Virol. 65:2761-2765.
49. Winter, N., et al. 1995. Recombinant BCG strains expressing the SIV mac-251 nef gene induce proliferative and CTL responses against nef synthetic peptides in mice. Vaccine 13:471-478.
50. Xu, Y. G., and Y. J. Li. 2007. Induction of immune responses in mice after intragastric administration of Lactobacillus casei producing porcine parvovirus VP2 protein. Appl. Environ. Microbiol. 73:7041-7047.
51. Xu, Y. G., and Y. J. Li. 2008. Construction of recombinant Lactobacillus casei efficiently surface displayed and secreted porcine parvovirus VP2 protein and comparison of the immune responses induced by oral immunization. Immunology 124:68-75.
52. Zhou, F., B. T. Rouse, and L. Huang. 1992. Induction of cytotoxic T lymphocytes in vivo with protein antigen entrapped in membranous vehicles. J. Immunol. 149:1599-1604.